We are live on !
Find out more
Formula Growth Portfolio holdings
AUM
$284M
Turnover
33.14%
1-Year Est. Return
54.56%
This Fund
S&P 500
This Quarter Est. Return
+39.63%
1 Year Est. Return
+54.56%
3 Year Est. Return
+117.67%
5 Year Est. Return
+78.26%
10 Year Est. Return
+276.27%
AUM
$284M
AUM Growth
+$62.7M
(+28%)
Cap. Flow
+$6.37M
Cap. Flow % of AUM
Cap. Flow %
2.24%
Top 10 Holdings %
Top 10 Hldgs %
22.84%
Holding
169
New
32
Increased
28
Reduced
43
Closed
24
Avg Time Held
2.8
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Calix
CALX
|
+$3.23M |
| 2 |
Klaviyo
KVYO
|
+$2.49M |
| 3 |
Guardant Health
GH
|
+$2.1M |
| 4 |
EquipmentShare.com Inc
EQPT
|
+$1.66M |
| 5 |
AEVEX Corp
AVEX
|
+$1.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$6.75M |
| 2 |
Nokia
NOK
|
+$3.54M |
| 3 |
Forgent Power Solutions
FPS
|
+$2.4M |
| 4 |
Navan Inc
NAVN
|
+$1.85M |
| 5 |
ArcBest
ARCB
|
+$1.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.94% |
| 2 | Industrials | 25.15% |
| 3 | Healthcare | 16.98% |
| 4 | Consumer Discretionary | 12.68% |
| 5 | Financials | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
RadNet
RDNT
$5.78B
| $1.06M | 0.37% |
17,176
| – | – |
2023 Q3
11 quarters
|
|
102
Encompass Health
EHC
$13.4B
| $1.05M | 0.37% |
10,340
-63
| -0.6% | -$6.52K |
2025 Q3
3 quarters
|
|
103
Cellebrite
CLBT
$3.05B
| $1.02M | 0.36% |
70,000
+20,000
| +40% | +$264K |
2026 Q1
1 quarter
|
|
104
RXO
RXO
$4.53B
| $966K | 0.34% |
35,000
-10,000
| -22% | -$221K |
2022 Q4
14 quarters
|
|
105
CoStar Group
CSGP
$12.1B
| $963K | 0.34% |
34,000
| – | – |
2015 Q4
42 quarters
|
|
106
Victoria's Secret
VSXY
$7.71B
| $960K | 0.34% |
+11,500
| New | +$689K |
2026 Q2
0 quarters
|
|
107
Euronet Worldwide
EEFT
$2.36B
| $951K | 0.33% |
13,000
| – | – |
2015 Q4
42 quarters
|
|
108
DexCom
DXCM
$30.7B
| $926K | 0.33% |
13,744
-112
| -0.8% | -$7.46K |
2023 Q4
10 quarters
|
|
109
RingCentral
RNG
$6.8B
| $897K | 0.32% |
23,000
| – | – |
2015 Q4
42 quarters
|
|
110
Dolby
DLB
$5.81B
| $836K | 0.29% |
15,900
| – | – |
2018 Q2
32 quarters
|
|
|
MRX
111
Marex Group Limited Ordinary Shares
MRX
$4.63B
| $835K | 0.29% |
+13,700
| New | +$754K |
2026 Q2
0 quarters
|
|
112
Pulse Biosciences
PLSE
$3.73B
| $832K | 0.29% |
30,000
| – | – |
2026 Q1
1 quarter
|
|
113
WESCO International
WCC
$16.7B
| $794K | 0.28% |
2,300
-1,000
| -30% | -$339K |
2025 Q4
2 quarters
|
|
114
Qualcomm
QCOM
$176B
| $776K | 0.27% |
+4,200
| New | +$785K |
2026 Q2
0 quarters
|
|
115
Vuzix
VUZI
$179M
| $725K | 0.26% |
250,000
+100,000
| +67% | +$315K |
2025 Q4
2 quarters
|
|
116
Inseego
INSG
$80.5M
| $723K | 0.25% |
+70,000
| New | +$938K |
2026 Q2
0 quarters
|
|
117
Robert Half
RHI
$4.48B
| $688K | 0.24% |
+22,400
| New | +$627K |
2026 Q2
0 quarters
|
|
118
Sonos
SONO
$1.91B
| $676K | 0.24% |
50,000
+23,000
| +85% | +$337K |
2026 Q1
1 quarter
|
|
119
Interactive Brokers
IBKR
$34.8B
| $662K | 0.23% |
+7,600
| New | +$633K |
2026 Q2
0 quarters
|
|
120
Plexus
PLXS
$5.54B
| $661K | 0.23% |
+2,200
| New | +$574K |
2026 Q2
0 quarters
|
|
121
Oklo
OKLO
$4.7B
| $658K | 0.23% |
12,567
+4,967
| +65% | +$310K |
2026 Q1
1 quarter
|
|
122
Nike
NKE
$57.4B
| $616K | 0.22% |
+15,000
| New | +$660K |
2026 Q2
0 quarters
|
|
123
Ivanhoe Electric
IE
$1.23B
| $611K | 0.22% |
63,598
+45,000
| +242% | +$568K |
2025 Q1
5 quarters
|
|
124
EverQuote
EVER
$828M
| $606K | 0.21% |
25,469
-14,531
| -36% | -$266K |
2026 Q1
1 quarter
|
|
125
CeriBell Inc
CBLL
$1.02B
| $603K | 0.21% |
31,000
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
CWMGP
Formula Growth's Q2 2026 Portfolio in Review
As of Q2 2026, Formula Growth held 169 positions worth $284M, up 28% from $222M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Formula Growth's Q2 2026 filing shows 32 new, 28 increased, 43 reduced and 24 closed positions. Its largest new stake was Guardant Health: 19,300 shares worth $2.9M. The largest sale was Micron Technology, an estimated $6.75M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Industrials and Healthcare.
- Formula Growth's largest Q2 2026 buy was Guardant Health: 19,300 shares worth $2.9M.
- Formula Growth added most to Calix in Q2 2026, an estimated $3.23M increase.
- Formula Growth's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $6.75M.
- Formula Growth fully exited Navan Inc in Q2 2026, selling an estimated $1.85M.
- Formula Growth's ten largest holdings make up 23% of its $284M portfolio in Q2 2026.
- Formula Growth opened 32 new positions and closed 24 in Q2 2026.
- Formula Growth's portfolio value rose 28% quarter-over-quarter to $284M.
Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.